Tecentriq 1200mg Injection
Marketer
Roche Products India Pvt Ltd
Salt Composition
Atezolizumab (60mg/ml)
Overview Tecentriq 1200mg Injection
Atezolizumab 1200mg Injection, a monoclonal antibody therapy, treats various cancers including non-small cell lung cancer, small cell lung cancer, liver cancer (hepatocellular carcinoma), and melanoma. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Benefits may not be apparent immediately; continue treatment unless directed otherwise. Frequent side effects include tiredness, nausea, reduced appetite, constipation, cough, and breathlessness. Seek immediate medical attention for chest pain, diarrhea, or dark urine. Report any bothersome side effects to your doctor for potential management strategies. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, and all medications, including those for infections, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners. A patient support program exists in India, facilitated by Tata 1mg; inquire with your physician or call 1800-102-1618 for details.
Primary Ingredients of Tecentriq 1200mg Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Tecentriq 1200mg Injection
Therapeutic management of small cell and non-small cell lung cancers, melanoma, and hepatocellular carcinoma.
Major Benefits of Tecentriq 1200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Tecentriq 1200mg Injection:
- Fatigue
- Weakness
- Decreased appetite
- Nausea
- Cough
- Breathlessness
- Constipation
How to use Tecentriq 1200mg Injection:
This medication will be administered by your physician or their registered nurse; please refrain from self-medication.
How Tecentriq 1200mg Injection works:
Atezolizumab 1200mg injection, a monoclonal antibody, inhibits a protein on T lymphocytes—immune system regulating white blood cells. This blockade reactivates T-cell cytotoxicity, enhancing the immune response to identify and eliminate malignant cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tecentriq 1200mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Tecentriq 1200mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Atezolizumab injection (1200mg) likely poses a risk during lactation. Available human data indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCONSULT YOUR DOCTOR
The effect of a 1200mg Tecentriq injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Tecentriq 1200mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Tecentriq 1200mg Injection use in patients with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Tecentriq 1200mg Injection :
NA
Facts to Know About Tecentriq 1200mg Injection
| Label | Value |
|---|---|
| Chemical Type | Short Chains of Amino Acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | PD-1 Checkpoint Blockade Therapy |



